Elevance blocks deposition of former Medicare Advantage chief as DOJ seeks testimony
Elevance Health told the Justice Department it would not make Peter Haytaian, an outgoing executive who oversaw its Medicare Advantage plans, available for a deposition, the agency said in a letter to a judge. The company announced Haytaian’s departure shortly after the DOJ first requested his testimony.
The dispute is part of a broader Medicare Advantage fraud lawsuit the DOJ launched in 2020, alleging improper practices in the insurer’s private Medicare plans for seniors. Those plans generated more than $40 billion in revenue last year, underscoring the financial stakes.
The standoff adds to the scrutiny of Elevance’s Medicare business and could increase legal and financial pressures on the company as the case proceeds.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case”
read at STAT ↗
comments(0)
5-min edit window · permanent after that